Amani E. Khalifa
Cairo, C, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Retraction Notice to "Genistein improves sensorimotor gating: Mechanisms related to its neuroprotective effects on the striatum" [Neuropharm. 105 (2016) 35-46].
Journal: Neuropharmacology
Published: April 21, 2024
Retraction Note: Effects of genistein on pentylenetetrazole-induced behavioral and neurochemical deficits in ovariectomized rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 14, 2024
Control and treatment of type 2 diabetes in private patients in the Egyptian "DIACONTROL study".
Journal: European review for medical and pharmacological sciences
Published: December 14, 2023
Retraction Note to: Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 27, 2023
Factors hindering the implementation of clinical pharmacy practice in Egyptian hospitals.
Journal: Pharmacy practice
Published: December 11, 2021
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19.
Journal: Current research in pharmacology and drug discovery
Published: December 22, 2020
Ameliorative Effects of α-Tocopherol and/or Coenzyme Q10 on Phenytoin-Induced Cognitive Impairment in Rats: Role of VEGF and BDNF-TrkB-CREB Pathway.
Journal: Neurotoxicity research
Published: July 31, 2018
Retracted: Molecular mechanisms of neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: Impact on Sirt1/NRF2 signaling pathways.
Journal: Neurotoxicology
Published: April 06, 2018
Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Journal: Journal of cellular physiology
Published: September 02, 2017
Last Updated: 09/26/2026